Notice for International Patients & Caregivers

English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.

Provincial Landscape

Snapshot: 2026-09-04

Jiangsu Multiple Myeloma Active Trials & Centers

As of 2026-09-04, there are 37 active clinical trials for multiple myeloma hosted across 19 tertiary medical centers in Jiangsu (including Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, The Second Affiliated Hospital of Soochow University, The Affiliated Hospital of Xuzhou Medical University, etc.).

Active Trials

Hospitals

Therapies

CAR-T Cell Therapy / Bispecific & Multispecific Antibodies / Monoclonal Antibodies / Oral Small-Molecule Agents

Participating Medical Centers (19)

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical SchoolThe Second Affiliated Hospital of Soochow UniversityThe Affiliated Hospital of Xuzhou Medical UniversityJiangsu Province HospitalNanjing Drum Tower HospitalThe First Affiliated Hospital of Soochow UniversityChangzhou No. 1 People's HospitalAffiliated Hospital of Nantong UniversityAffiliated Hospital of Jiangnan University无锡市人民医院The First Affiliated Hospital of Soochow UniversityThe Second People's Hospital of Changzhou, Nanjing Medical UniversityZhongda Hospital, Southeast UniversityTaizhou People's HospitalNanjing Drum Tower Hospital (The Affiliated Drum Tower Hospital of Nanjing University Medical School)The First People's Hospital of LianyungangChangzhou Second People's HospitalYifu Hospital Affiliated to Nanjing Medical University徐州医学院附属医院

Active Studies in Jiangsu (37)

Population synthesized by CMDN

Showing 0 published English records of 37 registry trials.

All 37 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.

Back to National Landscape Filter Local Trials in the Trial Hub